CHARTA Shows Survival Benefit of Four-Drug Regimen for Advanced CRC
This video examines results of the CHARTA trial, which tested first-line FOLFOX plus bevacizumab with or without irinotecan in patients with advanced colorectal cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Hans-Joachim Schmoll, MD, PhD Tags: Conferences/ASCO 2017 Gastrointestinal Cancers Symposium Videos Gastrointestinal Cancers Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Colorectal Cancer | Conferences | Gastroenterology